Market Place
Sourcing Support
Elutia Posts Strong Q3, Accelerates EluPro® Launch to 2025
14 Nov 2024 //
GLOBENEWSWIRE
Elutia to Attend Canaccord Genuity MedTech Forum 2024
13 Nov 2024 //
GLOBENEWSWIRE
Elutia to Report Q3 2024 Financial Results on Nov 14, 2024
29 Oct 2024 //
GLOBENEWSWIRE
Elutia Presents at LD Micro Main Event XVII on October 30
23 Oct 2024 //
GLOBENEWSWIRE
Elutia Publishes Data On EluPro Antibiotic-Eluting Envelope
18 Sep 2024 //
GLOBENEWSWIRE
Elutia Celebrates First Year
06 Sep 2024 //
GLOBENEWSWIRE
Elutia Announces First Patient Implant Of EluPro BioEnvelope
05 Sep 2024 //
GLOBENEWSWIRE
Elutia to Participate in Upcoming Investor Conferences
03 Sep 2024 //
GLOBENEWSWIRE
Berkeley Biologics Receives FDA Warning Letter
27 Aug 2024 //
FDA
Elutia Announces Second Quarter 2024 Results
07 Aug 2024 //
GLOBENEWSWIRE
Elutia Announces $15.7M From Full Exercise Of Warrants
01 Aug 2024 //
GLOBENEWSWIRE
Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
31 Jul 2024 //
GLOBENEWSWIRE
Elutia To Report Q2 2024 Results On August 7
30 Jul 2024 //
GLOBENEWSWIRE
Elutia to Present at the Emerging Growth Conference on Thursday, July 18
11 Jul 2024 //
GLOBENEWSWIRE
Elutia Announces FDA Clearance Of EluPro® For Cardiac Pacemakers
17 Jun 2024 //
GLOBENEWSWIRE
Elutia Announces $13.26 Million Registered Direct Offering
17 Jun 2024 //
GLOBENEWSWIRE
Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024
13 May 2024 //
GLOBENEWSWIRE
Elutia Q1 2024: SimpliDerm Up 55%, CanGaroo FDA Clearance In Q2
09 May 2024 //
GLOBENEWSWIRE
Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
02 May 2024 //
GLOBENEWSWIRE
Elutia to Present at Planet MicroCap Showcase: VEGAS 2024
24 Apr 2024 //
GLOBENEWSWIRE
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results
07 Mar 2024 //
GLOBENEWSWIRE
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results
22 Feb 2024 //
GLOBENEWSWIRE
Elutia Regains Compliance with Nasdaq Listing Requirements
10 Jan 2024 //
GLOBENEWSWIRE
Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products
13 Nov 2023 //
GLOBENEWSWIRE
Elutia Completes Divestiture of Orthobiologics Business Unit
09 Nov 2023 //
GLOBENEWSWIRE
Elutia to Report Third Quarter 2023 Financial Results
06 Nov 2023 //
GLOBENEWSWIRE
Elutia to Participate in Discussion at the Cantor Global Healthcare Conference
20 Sep 2023 //
GLOBENEWSWIRE
Elutia Announces Private Placement for Proceeds Up to $26 Million
19 Sep 2023 //
GLOBENEWSWIRE
Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds
18 Sep 2023 //
GLOBENEWSWIRE
Aziyo Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices
06 Sep 2023 //
GLOBENEWSWIRE
Aziyo Biologics Announces Publication of a CanGaroo® Case Study
30 Aug 2023 //
GLOBENEWSWIRE
Aziyo Biologics Reports Second Quarter 2023 Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
Aziyo Biologics to Report Second Quarter 2023 Financial Results
31 Jul 2023 //
GLOBENEWSWIRE
Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products
13 Jul 2023 //
GLOBENEWSWIRE
Aziyo Biologics Presents Positive Clinical Data on CanGaroo Biologic Envelope
19 May 2023 //
GLOBENEWSWIRE
Aziyo Biologics Reports Highest Sales and Gross Profit in Company History
10 May 2023 //
GLOBENEWSWIRE
Aziyo Biologics to Report 1Q 2023 FYR on Wednesday, May 10, 2023
03 May 2023 //
GLOBENEWSWIRE
Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo
20 Apr 2023 //
GLOBENEWSWIRE
